<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000044940"><TermName>MS 209</TermName><TermDefinition><DefinitionText>A substance that is being studied for its ability to make cancer cells respond better to chemotherapy drugs to which they have become resistant. It is a type of quinolone antibiotic.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>MS 209</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio por su capacidad para hacer que las células cancerosas respondan mejor a los medicamentos quimioterapéuticos a los que se volvieron resistentes. Es un tipo de antibiótico de quinolona.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2008-07-22</DateLastModified></GlossaryTerm>
